Regulatory dna sequence
CA 2025083 A1 · Owner: Novartis Ag · Inventors: Shinshi, Hideaki; Neuhaus, Jean-Marc; Meins, Frederick, Jr.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
CA Case GA/5-17740/=, Regulatory DNA sequence Abstract, The present invention relates to a novel substantially pure, regulatory DNA sequence that is obtainable from the 5' region of a plant chitinase gene and that in operable linkage with, any desired expressible DNA leads to greatly increased levels of expression in transformed plants. The present invention relates also to recombinant DNA molecules that contain the DNA sequence according to the invention in operable linkage with an expressible DNA and to, the vectors derived therefrom, and also to host cells and/or host organisms including, transgenic plants, that contain the said recombinant DNA or the vectors derived therefrom. The …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 11, 1990. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 11, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 11, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.